Verdiva Bio’s once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences.
Op-ed: TVs miss opportunity for real improvement by prioritizing corporate needs.
Ampere designs processors for data center systems based on Arm’s architecture
ALAFIA AI’s supercomputer accelerates AI workflows in healthcare, reducing task times from 30-60 minutes to under 30 seconds.
It promises 99 percent accuracy.
West Virginia gave obesity drugs to teachers and state employees—then took them away. December 12, 2024 A few years ago, West Virginia, which has the…
For the world’s largest users of golf carts by non golfers.
UnitedHealth Group and Amedisys claim in a court filing the government has failed to define where the deal would stifle competition.
The bananas are a rich source of potassium, the fat-free Greek yogurt packs a protein punch and this dessert has zero saturated fat.
Artificial intelligence tools are helping hospitals move patients more quickly into post-acute care and keep track of them while they recuperate.
Nature Cancer – Shukla and colleagues study the genomic and transcriptomic data of exceptional responders to immunotherapy in renal cell carcinoma and find that such…
